Children with Type 1 diabetes may achieve better blood-sugar control if their parents are more authoritative with them, a new study has found….

A new study finds that people who chew their food more take in fewer calories, which may help them control their weight. 

Americans downed nearly a quarter less added sugar in 2008 than they did nine years earlier, a new report concludes.…

Patients with diabetes who also suffer from depression are more likely to develop a serious complication known as diabetic retinopathy, a disease that damages the eye’s retina, and causes blindness, a five-year study finds….

With this special bonus edition of our highly successful GLP-1 special series, we provide you with an easy list so you can find all of our analyses in one place…. Just click on these links to access each analysis. GLP-1 Knowledge Survey Part I GLP-1 Knowledge Survey Part II GLP-1 …

We are all familiar with the phrase, “Save the Best for Last,” and as we finish up our special GLP-1 Series, we have done exactly that. This week we have the completion of an interview that our publisher, Steve Freed, did with Dr. David D’Alessio, Associate Professor of Medicine, Division …

In a special bonus issue of our GLP-1 Special Series, we presented this excellent and informative interview with Dr. Alan Moses, Global CMO, Novo Nordisk. Dr. Moses gave us his take on the latest in GLP-1 technologies as well as a peek at Novo’s efforts in developing world-class therapies in …

Diabetes In Control Publisher Steve Freed interviewed Dr. David D’Alessio, Associate Professor of Medicine, Division of Endocrinology, University of Cincinnati, and the Albert Vontz chair in Diabetes Research. Dr. D’Alessio helps us understand some of the newest research on GLP-1’s, how he uses these therapies in his own practice and …

Edited by Trisha Dunning AM, RN, MEd, PhD, CDE, FRCNA and Glenn Ward MBBS, BSc, DPhil (Oxon), FRACP, FRCPath Mr. VR was referred to the endocrinology department of a major hospital to ‘get his diabetes fixed up’ after he presented to the emergency department. Mr. VR is a 69-year-old man …

Topics covered include the clinical effects of GLP-1 agonists and DPP-4 inhibitors stemming from incretin action, and the role of glucagon in glucose intolerance and effects of GLP-1 based drugs on plasma glucagon…. Link to download (.ppt format): GLP-1 Effectiveness, Mechanisms of Action and Potential, Part 1 of 4 Other sets …